Does AbbVie's Viekira Pak Warning Land Express Scripts in the Penalty Box?
Following an FDA safety warning, AbbVie's sweetheart deal with Express Scripts could turn sour. Could Gilead Sciences be the real winner here?
Diplomat Pharmacy's Stock Jumps On Strong Third Quarter Results
Diplomat Pharmacy's shares rally on a strong third quarter earnings report.
Acquisitions Propel Diplomat Pharmacy, Inc. to Strong Q3
The specialty pharmacy posts huge revenue and earnings increases.